BDBM261756 3-[5-Bromo-4-chloro-1-(cyclopropylmethyl)-1H-benzimidazol-2-yl]-9-ethyl-9H-carbazole::US9708311, 8

SMILES CCn1c2ccccc2c2cc(ccc12)-c1nc2c(Cl)c(Br)ccc2n1CC1CC1

InChI Key InChIKey=KTNMFGPDXMSNOH-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 261756   

TargetProstaglandin E2 receptor EP4 subtype(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM261756(3-[5-Bromo-4-chloro-1-(cyclopropylmethyl)-1H-benzi...)
Affinity DataIC50: 19.7nMT: 2°CAssay Description:4 μl of a cAMP-d2/cell suspension (625000 cells/ml) were added to a test plate containing the substance solutions already initially introduced (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/31/2018
Entry Details
US Patent